在临床光蛋白质组学中使用活动估计识别蛋白质激酶药物点
Kirill Pevzner1, Nitzan Simchi2, Gali Arad2
1Protai Bio, Ramat Gan, Israel. kirill@protai.bio.
Methods in molecular biology (Clifton, N.J.)
|March 31, 2025
概括
这项研究引入了一种新的方法来识别蛋白激酶作为癌症药物点,使用光蛋白质组学数据. 它强调了分析激酶活性如何揭示过度激活的激酶,用于精确瘤治疗.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
背景情况:
- 基因组学已经推进了癌症标识,但临床蛋白质组学和蛋白质组学尚未得到充分利用.
- 大规模的蛋白质组学数据集越来越多地来自CPTAC和PRIDE等联盟.
- 蛋白激酶是细胞过程的关键调节剂,也是癌症治疗中的关键标.
研究的目的:
- 描述蛋白激酶活性估计方法.
- 将这些方法应用于临床癌症光蛋白质组学数据集.
- 提出一种用于识别蛋白激酶作为治疗点的新方法.
主要方法:
- 对关键激酶活动估计算法的审查 (PTM-SEA,KSEA,Rokai,KStar,Kinome Atlas).
- 这些算法应用于临床光蛋白组学数据.
- 在特定癌症类型中识别过度激活的激酶.
主要成果:
- 在临床癌症样本中证明了过活化激酶的识别.
- 作为基准目标,强调了HER2和EGFR.
- 这项研究展示了将酶活性估计与蛋白质组学相结合的潜力.
结论:
- 将激酶活性估计与临床蛋白组学相结合,可以发现新的治疗点.
- 这种方法支持开发精密瘤疗法.
- 蛋白激酶活性分析为癌症药物发现提供了有价值的策略.
相关概念视频
02:54Protein Kinases and Phosphatases
12.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K